FDA Approves New EEG Test to Locate ADHD in Children’s Brains
July 20, 2013
The Food and Drug Administration (FDA) has approved a new testing system called Neuropsychiatric EEG-Based Assessment Aid (NEBA) System that measures electrical impulses that neurons give off within the brain to look for evidence of attention deficit hyperactivity disorder (ADHD) within a patient’s neural-net.
In less than a half an hour, the NEBA can calculate the ratio of specific brain wave frequencies such as theta na beta waves.
The target age group for NEBA is between 6 and 17.
Christy Foreman, director of the Office of Device Evaluation at the FDA’s Center for Devices and Radiological Health, commented : “Diagnosing ADHD is a multistep process based on a complete medical and psychiatric exam. The NEBA System along with other clinical information may help health care providers more accurately determine if ADHD is the cause of a behavioral problem.”
According to the FDA: “The theta/beta ratio has been shown to be higher in children and adolescents with ADHD than in children without it.”
It is believed that this new device “can help confirm an ADHD diagnosis” or “other medical or behavioral conditions that produce similar symptoms.”
In a study conducted in 2007 – 2008, researchers for the Centers for Disease Control and Prevention (CDC) found that:
• 2.7 million of the 4.1 million US school-aged children with ADHD were taking medication for treatment, based on parent report
• Boys were more likely than girls to be taking ADHD medication, at every age
• State-based rates of ADHD medication treatment among those with ADHD ranged from 33% in Nevada to 79% in Mississippi
• The lowest rates of medication usage were documented in 5 Western states (Nevada, California, Alaska, Hawaii, and New Mexico)
• The highest rates of medication usage were documented in 5 Southern states (North Carolina, Louisiana, West Virginia, Arkansas, and Delaware)
• The state-based variation in ADHD medication treatment supports reports by the Food and Drug Administration of uneven distribution of common ADHD medication, contributing to ADHD medication shortages in certain states
Diagnosing ADHD has become a concerted goal since psychiatrist Leon Eisenberg, “scientific father of ADHD” came out in his last interview before his death to admit that ADHD is a fictitious disease.
Eisenberg said: “ADHD is a prime example of a fictitious disease.”
The American Psychiatric Association (APA) has promoted Ritalin as the go-to medication for ADHD which has proven highly profitable to Ciba Pharmaceutical and the psychiatric community.
A study published in the New England Journal of Medicine by Dr. William Cooper, pediatrics and preventive medicine professor at Vanderbilt University, claims that Ritalin and Adderall (two pharmaceutical drugs used to treat ADHD) can prevent the mind of hyperactive children from becoming criminals. Cooper contends that these drugs should continue to be administered through adulthood to prevent criminal activity later in life.
Cooper said: “There definitely is a perception that it’s a disease of childhood and you outgrow your need for medicines. We’re beginning to understand that ADHD is a condition for many people that really lasts throughout their life.”
So far, 5% of the children in the US have been diagnosed with ADHD, a psychiatric disorder wherein the non-medical opinion of a psychologist that a child is hyperactive, impulsive, has difficulty paying attention and therefore must be given pharmaceutical drugs so that “focus in school” can be achieved.
The study analyzed court and prison records from 2006 – 2009 to determine the number of those convicted who were on a drug to treat SDHD; as well as the severity of their crimes. Only 10 control subjects were entered into the study.
The findings showed:
• Thirty – seven percent of convicts were pre – diagnosed with ADHD
• It was likely that ADHD medication was used in 32% of male convicts and 41% of female
• ADHD suffers were likely to commit burglary or theft
• Four thousand of the 23,000 crimes researched were violent
Dr. Andrew Adesman, chief of developmental and behavioral pediatrics at the Steven and Alexandra Cohen Children’s Medical Center, confirms through past research that adults who were diagnosed with ADHD as children are more likely to:
• Get into driving accidents
• Consistently lose jobs
• Divorce spouses
• Be arrested or commit some criminal activity
Adesman admits that not all children marked as ADHD go on to become criminals or divorcees, and that the majority of them simply grow out of the behavior. Yet, Adesman still maintains that despite the fact that ADHD is a phase of childhood that rarely carries into adulthood that “collectively, people with ADHD are at risk for a range of poor outcomes.”
Dr. Fred Baughman, child neurologist and ADHD researcher states that the advent of ADHD diagnoses is a scheme to sell more anti – psychotic drugs to young children by the pharmaceutical corporations in conjunction with the psychiatric community. Baughman insists that a normal development in children has now been socially accepted as a neurological disorder that requires psychiatric treatment.
Annually, Ritalin sales reach the billions and Adderall has unquestionably surpassed the once leading drug treatment for ADHD to become the drug of choice for pediatricians. However, doctors admit that the children “grow out of the symptoms of ADHD” and that none of the accepted pharmaceuticals actually cure the alleged disease.
Researchers, in keeping with the necessity for drugs to treat ADHD, claim that video games, television, and genetics are the causes of the “disease” while completely ignoring the chemical additives in processed foods that would be heightening a normal function in the neurological development of children.
Maida Galvez, M.D., director of pediatric environmental health at Mount Sinai School of Medicine, explains that: “Scientific evidence is limited to support the association between food additives and ADHD symptoms. Although it is possible that a very small group of children who are allergic to artificial colorings or preservatives may show improvement in symptoms on restriction diets, evidence is insufficient to recommend routine, widespread use of restriction diets to treat a child’s ADHD symptoms.”
Artificial food coloring in addition to the preservative sodium benzoate was shown in studies to incited hyperactivity in children that had not been previously diagnosed with ADHD.
Drug corporations that benefit from this scheme are:
• Johnson & Johnson
• Eli Lily
In 2010, there was an explosion of sales for drugs treating ADHD to the extent that manufacturers could not keep the drugs on the “shelf”. Without having a clear science of diagnosis, any psychiatrist could (and did) deem as many children as possible with this label for the sake of profits to the pharmaceutical industry as well as lending credibility to the interpretive world of psychiatry because this specialty analyses emotional responses and behaviors without using scientific measurements or knowledge of causational disturbances that are reflected in real, physical diseases.
ADHD is one of the most lucrative schemes concocted by the psychiatric community in order to justify the development of pharmaceutical drugs that were already in production.